GENF — Genflow Biosciences Balance Sheet
0.000.00%
- £3.52m
- £3.24m
Annual balance sheet for Genflow Biosciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.177 | 0.224 | 2.36 | 0.684 | 0.279 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 0.02 | 0.127 | 0.343 | 0.105 |
Prepaid Expenses | |||||
Total Current Assets | 0.18 | 0.277 | 2.62 | 1.07 | 0.384 |
Net Property, Plant And Equipment | — | — | 0.002 | 0.003 | 0.002 |
Total Assets | 0.18 | 0.277 | 2.62 | 1.07 | 0.386 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.031 | 0.221 | 0.251 | 0.346 | 0.789 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.031 | 0.221 | 0.251 | 0.346 | 0.789 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.149 | 0.055 | 2.37 | 0.726 | -0.403 |
Total Liabilities & Shareholders' Equity | 0.18 | 0.277 | 2.62 | 1.07 | 0.386 |
Total Common Shares Outstanding |